135 related articles for article (PubMed ID: 30489605)
1. Retinal Exudates and Hemorrhages in a Survivor of Breast Cancer.
Moussa K; Kim J; Miller JB
JAMA Ophthalmol; 2019 Feb; 137(2):218-219. PubMed ID: 30489605
[No Abstract] [Full Text] [Related]
2. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.
Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2006 Oct; 84(5):707-8. PubMed ID: 16965507
[No Abstract] [Full Text] [Related]
3. Volume Rendering of Optical Coherence Tomography Angiography Reveals Extensive Retinal Vascular Contributions to Neovascularization in Ocular Toxoplasmosis.
Spaide RF
Retina; 2015 Nov; 35(11):2421-2. PubMed ID: 26405767
[No Abstract] [Full Text] [Related]
4. Rapid regression of retinal neovascularization following intravitreal bevacizumab in branch retinal vein occlusion imaged by optical coherence tomography angiography.
Brar M; Grewal DS; Sharma M; Grewal SPS
Indian J Ophthalmol; 2018 Apr; 66(4):572. PubMed ID: 29582824
[No Abstract] [Full Text] [Related]
5. SUBRETINAL NEOVASCULARIZATION IN MACULAR TELANGIECTASIA TYPE 2: OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY AND TREATMENT RESPONSE.
Tan GS; Kuehlewein L; Sadda SR; Sarraf D; Schwartz SD
Retin Cases Brief Rep; 2015; 9(4):286-9. PubMed ID: 26288110
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy.
Querques G; Prascina F; Iaculli C; Delle Noci N
Acta Ophthalmol; 2008 Sep; 86(6):700-1. PubMed ID: 18705681
[No Abstract] [Full Text] [Related]
7. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Rishi P; Rishi E; Shroff D
Indian J Ophthalmol; 2009; 57(3):241-2. PubMed ID: 19384026
[No Abstract] [Full Text] [Related]
8. Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.
Jorge R; Costa RA; Calucci D; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):1045-8. PubMed ID: 17136357
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2.
Narayanan R; Chhablani J; Sinha M; Dave V; Tyagi M; Pappuru RR; Kuppermann BD
Retina; 2012; 32(10):2001-5. PubMed ID: 22990322
[TBL] [Abstract][Full Text] [Related]
10. LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2.
Toygar O; Guess MG; Youssef DS; Miller DM
Retina; 2016 Nov; 36(11):2150-2157. PubMed ID: 27258671
[TBL] [Abstract][Full Text] [Related]
11. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
12. Treatment of Foveal Neovascularization in a Patient With Type 1 Diabetes.
Jao K; Northey LC; Essex RW
JAMA Ophthalmol; 2018 Sep; 136(9):e182584. PubMed ID: 30242368
[No Abstract] [Full Text] [Related]
13. Long term result of intravitreal bevacizumab in a patient newly transformed to proliferative macular telangiectasia type 2.
Ozkaya A; Alkin Z; Karakucuk Y; Yazici AT; Demirok A
Middle East Afr J Ophthalmol; 2013; 20(4):360-2. PubMed ID: 24339691
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein angiography of subretinal neovascular membrane in parafoveal telangiectasia type II demonstrating retino-retinal, retino-subretinal anastomosis.
Megur B; Megur D; Reddy S
Indian J Ophthalmol; 2016 Nov; 64(11):840-842. PubMed ID: 27958208
[No Abstract] [Full Text] [Related]
15. Diagnostic and Therapeutic Challenges.
Peng WY; Zhou SY; Ma J; Gross JG
Retina; 2022 Feb; 42(2):404-409. PubMed ID: 35050931
[No Abstract] [Full Text] [Related]
16. Type 3 Neovascularization (Retinal-Choroidal Anastomosis) in Childhood Coats' Disease.
Ramtohul P; Gascon P; Comet A
Ophthalmol Retina; 2019 Oct; 3(10):834. PubMed ID: 31585709
[No Abstract] [Full Text] [Related]
17. "Mommy... I Can't See With My Eye". Coats disease with foveal exudation (Stage 2b).
Yeung HH
J Pediatr Ophthalmol Strabismus; 2016; 53(2):76-7, 89. PubMed ID: 27018878
[No Abstract] [Full Text] [Related]
18. Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization.
Do DV; Bressler SB; Cassard SD; Gower EW; Tabandeh H; Jefferys JL; Bressler NM
Retina; 2014 Oct; 34(10):2063-71. PubMed ID: 24978428
[TBL] [Abstract][Full Text] [Related]
19. Pneumatic displacement and intravitreal bevacizumab in the management of subretinal haemorrhage caused by choroidal neovascularization.
Hasler PW; la Cour M; Villumsen J
Acta Ophthalmol Scand; 2007 Aug; 85(5):577-9. PubMed ID: 17559558
[No Abstract] [Full Text] [Related]
20. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
